EBR Systems (ASX:EBR) Surges 7.6% on Q4 Momentum: Time to Buy Before Full US Launch?

EBR Systems Gains Momentum Ahead of 2026 US Launch EBR Systems (ASX: EBR) is building serious momentum as it moves closer to a full US commercial launch in 2026. Shares…

ByUjjwal Maheshwari

08

Sep 2025

Healthcare Stocks Small Caps Stocks Tech Stocks Technology

Imricor Medical Systems (ASX:IMR): Is it the dark horse in the ASX medtech sector?

Imricor Medical Systems (ASX:IMR) is one of a handful of radiology stocks on the ASX, seeking to emulate the success of Pro Medicus (ASX:PME). There's no shortage of peers including…

ByNick Sundich

07

Jul 2025

Agriculture Stocks AI Stocks Airlines Bank Stocks Basic Materials Biotech Stocks Blue Chip Stocks Cannabis Stocks CleanTech Coal Stocks Cobalt Stocks Consumer Copper Stocks Cryptocurrencies Currency Cybersecurity Stocks Defence Stocks Dividend Stocks Education Education Stocks Energy Stocks ETF EV Stocks Financials Gaming Stocks Gold Stocks Graphite Stocks Green Investments Growth Stocks Healthcare Stocks Index Funds Industrials International Stocks Iron Ore Stocks Large Caps Life Sciences Lithium Stocks Mid Cap Stocks Mining Stocks Nickel Stocks Oil and Gas Stocks Palladium Stocks Penny Stocks Property Rare Earths Stocks Real Estate Resources Retail Safe Stocks Semiconductor stocks Silver stocks Small Caps Stocks Steel Stocks Tech Stocks Technology Telecommunications Stocks Travel Stocks Undervalued Stocks Uranium Stocks Vanadium Stocks

Here are Our 11 Top ASX Stocks to Buy in FY26: 1 From Each Sector!

It is a New Financial Year, so it's time to outline 11 Top ASX Stocks to Buy in FY26. Why 11 you might ask? Because 11 is the number of…

ByNick Sundich

18

Jul 2024

Education General Market news Mid Cap Stocks Penny Stocks Small Caps Stocks Tech Stocks Technology

6 ASX IPOs that bounced back with a vengeance after a nuanced debut

The list of ASX IPOs that bounced back is nowhere near as long as the list of IPOs that flopped and never recovered. This is because while it is easy…

ByNick Sundich

22

Jan 2024

Uncategorized

FDA approval for ASX health stocks: Which companies are close to the green light in 2024?

FDA approval for ASX health stocks is the dream that just about all emerging companies in the sector are aspiring to. Just over 12 months ago, we predicted that Neuren…

ByNick Sundich

EBR Systems (ASX:EBR) Surges 7.6% on Q4 Momentum: Time to Buy Before Full US Launch?

Imricor Medical Systems (ASX:IMR): Is it the dark horse in the ASX medtech sector?

Here are Our 11 Top ASX Stocks to Buy in FY26: 1 From Each Sector!

6 ASX IPOs that bounced back with a vengeance after a nuanced debut

FDA approval for ASX health stocks: Which companies are close to the green light in 2024?

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here